1. R. A. Floyd and K. Hensley, “Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases,” Neurobiol. Aging, 23, No. 5, 795–807 (2002).

2. X. H. Deng, G. Bertini, Y. Z. Xu, et al., “Cytokineinduced activation of glial cells in the mouse brain is enhanced at an advanced age,” Neuroscience, 141, No. 2, 645–661 (2006).

3. I. Rozovsky, C. E. Finch, and T. E. Morgan, “Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation,” Neurobiol. Aging, 19, No. 1, 97–103 (1998).

4. R. E. Mrak and W. S. Griffin, “Glia and their cytokines in progression of neurodegeneration,” Neurobiol. Aging, 26, No. 3, 349–354 (2005).

5. M. P. Mattson, “Apoptosis in neurodegenerative disorders,” Nat. Rev. Mol. Cell. Biol., 1, No. 2, 120–129 (2000).

6. M. P. Mattson, “Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders,” Antioxid. Redox Signal., 8, Nos. 11/12, 1997–2006 (2006).

7. R. M. Friedlander, “Apoptosis and caspases in neurodegenerative diseases,” New Engl. J. Med., 348, No. 14, 1365–1375 (2003).

8. C. M. Troy and G. S. Salvesen, “Caspases in the brain,” J. Neurosci. Res., 69, No. 2, 145–150 (2002).

9. S. M. McCann, “The nitric oxide hypothesis of brain aging,” Exp. Gerontol., 32, Nos. 4/5, 431–440 (1997).

10. A. Navarro and A. Boveris, “Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants,” Adv. Drug. Deliv. Rev., 60, 1534–1544 (2008).

11. P. K. Kim, Y. G. Kwon, H. T. Chung, and Y. M. Kim, “Regulation of caspases by nitric oxide,” Ann. New York Acad. Sci., 962, 42–52 (2002).

12. J. Sastre, F. V. Pallardó, and J. Viña, “Mitochondrial oxidative stress plays a key role in aging and apoptosis,” IUBMB Life, 49, No. 5, 427–435 (2000).

13. M. E. Götz, E. Ahlbom, B. Zhivotovsky, et al., “Radical scavenging compound J 811 inhibits hydrogen peroxideinduced death of cerebellar granule cells,” J. Neurosci. Res., 56, No. 4, 420–426 (1999).

14. A. M. Stranahan and M. P. Mattson, “Recruiting adaptive cellular stress responses for successful brain ageing,” Nat. Rev. Neurosci., 13, No. 3, 209–216 (2012).

15. M. Tajes Orduña, C. Pelegrí Gabalda, J. Vilaplana Hortensi, et al., “An evaluation of the neuroprotective effects of melatonin in an in vitro experimental model of age-induced neuronal apoptosis,” J. Pineal Res., 46, No. 3, 262–267 (2009).

16. Y. Hong, K. J. Palaksha, K. Park, et al., “Melatonin plus exercise-based neurorehabilitative therapy for spinal cord injury,” J. Pineal Res., 49, No. 3, 201–209 (2010).

17. A. Leja-Szpak, J. Jaworek, P. Pierzchalski, and R. J. Reiter, “Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1),” J. Pineal Res., 49, No. 3, 248–255 (2010).

18. R. Hardeland, D. X. Tan, and R. J. Reiter, “Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines,” J. Pineal Res., 47, No. 2, 109–126 (2009).

19. K. G. Akbulut, B. Gonul, and H. Akbulut, “Exogenous melatonin decreases age-induced lipid peroxidation in the brain,” Brain Res., 1238, 31–35 (2008).

20. A. R. Meki, D. Esmail Eel, A. A. Hussein, and H. M. Hassanein, “Caspase-3 and heat shock protein-70 in rat liver treated with aflatoxin B1: effect of melatonin,” Toxicon, 43, No. 1, 93–100 (2004).

21. L. Casciola-Rosen, D. W. Nicholson, T. Chong, et al., “Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death,” J. Exp. Med., 183, No. 5, 1957–1964 (1996).

22. K. M. Miranda, M. G. Espey, and D. A. Wink, “A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite,” Nitric Oxide, 5, No. 1, 62–71 (2001).

23. A. M. Lynch and M. A. Lynch, “The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation,” Eur. J. Neurosci., 15, No. 11, 1779–1788 (2002).

24. M. K. Lucin and T. Wyss-Coray, “Immune activation in brain aging and neurodegeneration: too much or too little?” Neuron, 64, No. 1, 110–122 (2009).

25. G. E. Landreth, “Microglia in central nervous system diseases,” J. Neuroimmune Pharmacol., 4, No. 4, 369–370 (2009).

26. J. P. Godbout and R. W. Johnson, “Age and neuroinflammation: a lifetime of psychoneuroimmune consequences,” Immunol. Allergy Clin. North Am., 29, No. 2, 321–337 (2009).

27. E. Siles, E. Martínez-Lara, A. Cañuelo, et al., “Agerelated changes of the nitric oxide system in the rat brain,” Brain Res., 956, No. 2, 385–392 (2002).

28. A. Law, S. Doré, S. Blackshaw, et al., “Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long-Evans rats,” Neuroscience, 100, No. 4, 769–775 (2000).

29. D. Vernet, J. J. Bonavera, R. S. Swerdloff, et al., “Spontaneous expression of inducible nitric oxide synthase in the hypothalamus and other brain regions of aging rats,” Endocrinology, 139, No. 7, 3254–3261 (1998).

30. P. Liu, Y. Jing, and H. Zhang, “Age-related changes in arginine and its metabolites in memory-associated brain structures,” Neuroscience, 164, No. 2, 611–628 (2009).

31. S. Blanco, F. J. Molina, L. Castro, et al., “Study of the nitric oxide system in the rat cerebellum during aging,” BMC Neurosci., 11, 78 (2010).

32. C. Hutton, B. Draganski, J. Ashburner, and N. Weiskopf, “A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging,” Neuroimage, 48, No. 2, 371–380 (2009).

33. A. Schuitemaker, T. F. van der Doef, R. Boellaard, et al., “Microglial activation in healthy aging,” Neurobiol. Aging, 33, No. 6, 1067–1072 (2012).

34. X. G. Luo, J. Q. Ding, and S. D. Chen, “Microglia in the aging brain: relevance to neurodegeneration,” Mol. Neurodegener., 5, 12 (2010).

35. A. Das, A. Belagodu, R. J. Reiter, et al., “Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress,” J. Pineal Res., 45, No. 2, 117–124 (2008).

36. K. G. Akbulut, H. Akbulut, N. Akgun, and B. Gonul, “Melatonin decreases apoptosis in gastric mucosa during aging,” Aging Clin. Exp. Res., 24, No. 1, 15–20 (2012).

37. Y. Zhang, E. Chong, and B. Herman, “Age-associated increases in the activity of multiple caspases in Fisher 344 rat organs,” Exp. Gerontol., 37, No. 6, 777–789 (2002).

38. A. Zhang, D. E. Lorke, S. X. Wu, and D.T. Yew, “Caspase-3 immunoreactivity in different cortical areas of young and aging macaque (Macaca mulatta) monkeys,” Neurosignals, 15, No. 2, 64–73 (2007).